4-(1-(benzo[d][1,3]dioxol-5-yl)-2-(6-methylpyridin-2-yl)-1H-imidazol-4-yl)benzamide

ID: ALA551623

Chembl Id: CHEMBL551623

PubChem CID: 45270334

Max Phase: Preclinical

Molecular Formula: C23H18N4O3

Molecular Weight: 398.42

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1

Standard InChI:  InChI=1S/C23H18N4O3/c1-14-3-2-4-18(25-14)23-26-19(15-5-7-16(8-6-15)22(24)28)12-27(23)17-9-10-20-21(11-17)30-13-29-20/h2-12H,13H2,1H3,(H2,24,28)

Standard InChI Key:  IVXWQGAVHUECAP-UHFFFAOYSA-N

Associated Targets(Human)

TGFBR1 Tchem TGF-beta receptor type I (3786 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACVR1B Tchem Activin receptor type-1B (1131 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACVR1C Tbio Activin receptor type-1C (35 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 398.42Molecular Weight (Monoisotopic): 398.1379AlogP: 3.74#Rotatable Bonds: 4
Polar Surface Area: 92.26Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.89CX LogP: 3.57CX LogD: 3.57
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.57Np Likeness Score: -1.17

References

1. Li X, Wang L, Long L, Xiao J, Hu Y, Li S..  (2009)  Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles and 1,3,5-trisubstituted pyrazoles as inhibitors of transforming growth factor beta type 1 receptor (ALK5).,  19  (16): [PMID:19616940] [10.1016/j.bmcl.2009.04.066]
2. Guo C, Zhang C, Li X, Li W, Xu Z, Bao L, Ding Y, Wang L, Li S..  (2013)  Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles as inhibitors of transforming growth factor-β type I receptor (ALK5).,  23  (21): [PMID:24055046] [10.1016/j.bmcl.2013.08.105]

Source